Research

Most Recent

A Push and a Pull for PARP-1 in Aging

By | August 1, 2005

Understanding the mechanisms that underlie aging remains a bedeviling problem, but not because of a lack of answers.

0 Comments

Plant Neurobiology Sprouts Anew

By | July 18, 2005

Understanding the mechanisms that underlie aging remains a bedeviling problem, but not because of a lack of answers.

1 Comment

Cancer Epigenetics Enters the Mainstream

By | June 20, 2005

Understanding the mechanisms that underlie aging remains a bedeviling problem, but not because of a lack of answers.

0 Comments

MicroRNA Target Practice

By | June 20, 2005

Understanding the mechanisms that underlie aging remains a bedeviling problem, but not because of a lack of answers.

0 Comments

"Industrial" Pollutants Reveal a Surprising Origin

By | June 6, 2005

Understanding the mechanisms that underlie aging remains a bedeviling problem, but not because of a lack of answers.

0 Comments

Secondary Endosymbiosis Exposed

By | June 6, 2005

Understanding the mechanisms that underlie aging remains a bedeviling problem, but not because of a lack of answers.

0 Comments

Turning Back the Tuberculosis Tide

By | May 23, 2005

Understanding the mechanisms that underlie aging remains a bedeviling problem, but not because of a lack of answers.

0 Comments

Longevity

By | May 9, 2005

Understanding the mechanisms that underlie aging remains a bedeviling problem, but not because of a lack of answers.

0 Comments

Taking the Lid Off the Molecular Garbage Pail

By | May 9, 2005

Understanding the mechanisms that underlie aging remains a bedeviling problem, but not because of a lack of answers.

0 Comments

A Peek at the Pore

By | April 25, 2005

Understanding the mechanisms that underlie aging remains a bedeviling problem, but not because of a lack of answers.

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech